Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
New York, NY
SEC filing record 1 source field available
Fiscal year end
31 December
Indaptus Therapeutics, Inc. has filed 324 SEC EDGAR filings since 20 Apr 2021

SEC filing history

Showing 1-25 of 324 matching filings.

Per page
25
Current page
1
DEF 14A File 001-40652

DEF 14A

Filing date
16 Jul 2026
Reporting date
16 Jul 2026
Next action
Verify source filing
SCHEDULE 13D/A File 005-92776

SCHEDULE 13D/A filing

Filing date
26 Jun 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13D/A File 005-92776

SCHEDULE 13D/A filing

Filing date
26 Jun 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13D/A File 005-92776

SCHEDULE 13D/A filing

Filing date
26 Jun 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13D/A File 005-92776

SCHEDULE 13D/A filing

Filing date
26 Jun 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 001-40652

PRE 14A

Filing date
22 Jun 2026
Reporting date
22 Jun 2026
Next action
Verify source filing
SCHEDULE 13D/A File 005-92776

SCHEDULE 13D/A filing

Filing date
29 Apr 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
20 Apr 2026
Reporting date
08 Apr 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-92776

SCHEDULE 13G/A filing

Filing date
06 Apr 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3

Filing date
02 Apr 2026
Reporting date
23 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3

Filing date
02 Apr 2026
Reporting date
23 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3

Filing date
02 Apr 2026
Reporting date
23 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13D File 005-92776

SCHEDULE 13D filing

Filing date
30 Mar 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13D/A File 005-92776

SCHEDULE 13D/A filing

Filing date
24 Mar 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
24 Mar 2026
Reporting date
23 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .